WO2006023876A1 - Method and apparatus for preparing water having increased oxygen solubility - Google Patents
Method and apparatus for preparing water having increased oxygen solubility Download PDFInfo
- Publication number
- WO2006023876A1 WO2006023876A1 PCT/US2005/029845 US2005029845W WO2006023876A1 WO 2006023876 A1 WO2006023876 A1 WO 2006023876A1 US 2005029845 W US2005029845 W US 2005029845W WO 2006023876 A1 WO2006023876 A1 WO 2006023876A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- water
- oxygen
- cell
- conduit
- thyristor
- Prior art date
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 102
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 title claims abstract description 55
- 239000001301 oxygen Substances 0.000 title claims abstract description 54
- 229910052760 oxygen Inorganic materials 0.000 title claims abstract description 54
- 238000000034 method Methods 0.000 title claims abstract description 40
- 238000006243 chemical reaction Methods 0.000 claims description 21
- 239000012530 fluid Substances 0.000 claims description 4
- 238000002955 isolation Methods 0.000 claims description 4
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 3
- 238000010304 firing Methods 0.000 claims description 3
- 229910052710 silicon Inorganic materials 0.000 claims description 3
- 239000010703 silicon Substances 0.000 claims description 3
- 230000001960 triggered effect Effects 0.000 claims description 3
- 239000000203 mixture Substances 0.000 abstract description 3
- 238000012360 testing method Methods 0.000 description 43
- 210000004027 cell Anatomy 0.000 description 38
- 230000035622 drinking Effects 0.000 description 25
- 208000002193 Pain Diseases 0.000 description 24
- 230000000694 effects Effects 0.000 description 16
- 239000008399 tap water Substances 0.000 description 15
- 235000020679 tap water Nutrition 0.000 description 15
- 230000008569 process Effects 0.000 description 11
- 230000003068 static effect Effects 0.000 description 11
- 206010022562 Intermittent claudication Diseases 0.000 description 9
- 208000024980 claudication Diseases 0.000 description 9
- 239000007788 liquid Substances 0.000 description 8
- 210000003141 lower extremity Anatomy 0.000 description 7
- 238000011084 recovery Methods 0.000 description 7
- 230000008901 benefit Effects 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 239000004800 polyvinyl chloride Substances 0.000 description 6
- 229910001220 stainless steel Inorganic materials 0.000 description 6
- 239000010935 stainless steel Substances 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- 229920000915 polyvinyl chloride Polymers 0.000 description 5
- 238000012549 training Methods 0.000 description 5
- 208000018262 Peripheral vascular disease Diseases 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 241000270281 Coluber constrictor Species 0.000 description 3
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 3
- 238000000692 Student's t-test Methods 0.000 description 3
- 230000000747 cardiac effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 229910001882 dioxygen Inorganic materials 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- OQZCSNDVOWYALR-UHFFFAOYSA-N flurochloridone Chemical compound FC(F)(F)C1=CC=CC(N2C(C(Cl)C(CCl)C2)=O)=C1 OQZCSNDVOWYALR-UHFFFAOYSA-N 0.000 description 3
- 150000002926 oxygen Chemical class 0.000 description 3
- 125000006850 spacer group Chemical group 0.000 description 3
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000001351 cycling effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000000302 ischemic effect Effects 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 239000008400 supply water Substances 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 229910000619 316 stainless steel Inorganic materials 0.000 description 1
- 200000000007 Arterial disease Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 238000005267 amalgamation Methods 0.000 description 1
- 230000037147 athletic performance Effects 0.000 description 1
- 235000012206 bottled water Nutrition 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000013101 initial test Methods 0.000 description 1
- 230000009878 intermolecular interaction Effects 0.000 description 1
- 208000023589 ischemic disease Diseases 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000006911 nucleation Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/48—Treatment of water, waste water, or sewage with magnetic or electric fields
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/46—Treatment of water, waste water, or sewage by electrochemical methods
- C02F1/461—Treatment of water, waste water, or sewage by electrochemical methods by electrolysis
- C02F1/46104—Devices therefor; Their operating or servicing
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/005—Systems or processes based on supernatural or anthroposophic principles, cosmic or terrestrial radiation, geomancy or rhabdomancy
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/46—Treatment of water, waste water, or sewage by electrochemical methods
- C02F1/4608—Treatment of water, waste water, or sewage by electrochemical methods using electrical discharges
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/46—Treatment of water, waste water, or sewage by electrochemical methods
- C02F1/461—Treatment of water, waste water, or sewage by electrochemical methods by electrolysis
- C02F1/467—Treatment of water, waste water, or sewage by electrochemical methods by electrolysis by electrochemical disinfection; by electrooxydation or by electroreduction
- C02F1/4672—Treatment of water, waste water, or sewage by electrochemical methods by electrolysis by electrochemical disinfection; by electrooxydation or by electroreduction by electrooxydation
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/46—Treatment of water, waste water, or sewage by electrochemical methods
- C02F1/461—Treatment of water, waste water, or sewage by electrochemical methods by electrolysis
- C02F1/46104—Devices therefor; Their operating or servicing
- C02F1/46109—Electrodes
- C02F2001/46133—Electrodes characterised by the material
- C02F2001/46138—Electrodes comprising a substrate and a coating
- C02F2001/46142—Catalytic coating
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2103/00—Nature of the water, waste water, sewage or sludge to be treated
- C02F2103/02—Non-contaminated water, e.g. for industrial water supply
- C02F2103/026—Treating water for medical or cosmetic purposes
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2201/00—Apparatus for treatment of water, waste water or sewage
- C02F2201/46—Apparatus for electrochemical processes
- C02F2201/461—Electrolysis apparatus
- C02F2201/46105—Details relating to the electrolytic devices
- C02F2201/4612—Controlling or monitoring
- C02F2201/46125—Electrical variables
- C02F2201/4613—Inversing polarity
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2201/00—Apparatus for treatment of water, waste water or sewage
- C02F2201/46—Apparatus for electrochemical processes
- C02F2201/461—Electrolysis apparatus
- C02F2201/46105—Details relating to the electrolytic devices
- C02F2201/4616—Power supply
- C02F2201/4617—DC only
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2201/00—Apparatus for treatment of water, waste water or sewage
- C02F2201/46—Apparatus for electrochemical processes
- C02F2201/461—Electrolysis apparatus
- C02F2201/46105—Details relating to the electrolytic devices
- C02F2201/4616—Power supply
- C02F2201/46175—Electrical pulses
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2209/00—Controlling or monitoring parameters in water treatment
- C02F2209/005—Processes using a programmable logic controller [PLC]
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2209/00—Controlling or monitoring parameters in water treatment
- C02F2209/02—Temperature
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2209/00—Controlling or monitoring parameters in water treatment
- C02F2209/03—Pressure
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2209/00—Controlling or monitoring parameters in water treatment
- C02F2209/40—Liquid flow rate
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2209/00—Controlling or monitoring parameters in water treatment
- C02F2209/42—Liquid level
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2301/00—General aspects of water treatment
- C02F2301/02—Fluid flow conditions
- C02F2301/022—Laminar
Definitions
- the invention is directed to an apparatus and a method for increasing the solubility of non-polar gases, such as oxygen in water.
- the apparatus includes at least one cell, each cell defining a conduit. At least two electrode plates are located in the conduit of the 25 cell. An electrical circuit is coupled to the electrode plates. The electrical circuit includes a thyristor, whereby activation of the electrical circuit administers an electrical pulse to the water or combination of water and oxygen gas conducted through the conduit.
- a method of increasing the solubility of water includes the steps of combining water with oxygen and treating the water by applying an electromagnetic pulse in an amount sufficient to cause water to dissolve the oxygen beyond the saturation point of untreated water.
- the invention is water having enhanced solubility for oxygen consequent to the method of the invention.
- enhanced-solubility water (ESW) formed by the apparatus and method of the invention can exhibit long-term stable or metastable oxygen cavities, e.g., when compared to conventionally oxygenated water.
- ESW can have increased oxygen solubility for at least one day.
- ESW can have in vivo stability and absorption with measurable physiological effects, as shown in Examples 1-5.
- ESW can be used to treat the symptoms of disease, and can improve exercise performance.
- the apparatus and method of the invention causes water to dissociate, whereby hydrogen gas (H 2 ) and oxygen gas (O 2 ) form. At least a portion of the oxygen gas formed is believed to be entrapped by an arrangement of the remaining molecules.
- the enhanced-solubility water formed by the apparatus and method of the invention can be employed, for example, to enhance athletic performance in humans.
- FIG 1 shows an apparatus 110 as one embodiment of the invention for preparing oxygen enriched water.
- FIG 2 shows a single exciter cell 210 which can be employed in apparatus 110.
- Fig. 1 shows apparatus 110 as one embodiment of the invention for preparing oxygen enriched water.
- potable water e.g., pre- filtered municipal treated water, spring water, and the like
- tank 116 e.g., a 4,000 US gallon stainless steel conical contact tank
- Water from tank 116 is recirculated from tank 116 via conduit 117, main system pump 120 and conduit 118 to reaction chamber 122.
- Water in reaction vessel 122 is converted to enhanced-solubility water, as described in detail below.
- the processed water including hydrogen gas (H 2 ) generated during conversion of the water, is directed via cell discharge header conduit 124, which enters the top of tank 116 vertically at the center of the tank and extends to a suitable depth, much as a depth of about 72 inchesAs excited (oxygen-enriched) water enters tank 116, it combines with the water in the tank, creating a mixture of semi-excited and excited water.
- Hydrogen gas (H 2 ) formed by the conversion and entrained with the converted water back to tank 116 can be released from tank 116 through vent 119.
- Main system pump 120 is controlled by frequency inverter 126 employing a proportional integral derivative (VJD) control loop.
- a second pump 128 also recirculates water from the bottom of tank 116 via conduit 130 through heat exchanger 132 and then returns the water to the top of tank 116 through conduit 134.
- Heat exchanger 132 can be employed to establish a temperature of the water in a range of between about 0.55 0 C and about 1.67 0 C. Heat exchanger 132 can employ any fluid known to the art, for example, ethylene glycol.
- a pressurized clean air blanket can be maintained on top of the water in tank 116 by providing clean pressurized air from air pump 136 through conduit 138, coalescing filter 140 and sanitary filter 142.
- the air blanket can extend about 12 inches down from the dome of tank 116, and can be maintained at a pressure of about 241 kilopascals.
- a programmed logic controller (PLC) 144 can employ an output instruction to control process variables, e.g., pressure, liquid levels, flow rates, and the like, of the apparatus shown in Fig. 1.
- the instructions can control the closed loop process using inputs from analog or digital input modules (e.g., pressure sensors, liquid level sensors, thermocouples, flow sensors, and the like) and provide a control output to analog or digital output modules (e.g., a pump, a valve, a heat exchanger, and the like) as a response that can be effective at holding a process variable at a desired set point.
- analog or digital input modules e.g., pressure sensors, liquid level sensors, thermocouples, flow sensors, and the like
- analog or digital output modules e.g., a pump, a valve, a heat exchanger, and the like
- Reaction chamber 122 can typically employ multiple exciter cells, for example, about 40 cells.
- the cells are housed in the reaction chamber 122.
- Fig. 2 shows a single cell 210.
- the cell can be constructed with rigid tubing 212, e.g., polyvinyl chloride (PVC) tubing, about 7.6 cm inside diameter and about 120 cm long.
- a rigid insulating spacer 214 e.g., made of PVC, is employed to hold the electrode plates 216.
- Electrode plates 216 can be about 5 cm wide, about 100 cm long titanium plates with about 100 micro-ohms coating of platinum. Plates 216 are held by spacer 214 in 2 sets (for positive and negative) of 4 plates each as shown.
- Plates 216 are spaced at about 6.4 millimeters between the two sets. Each set can be terminated with a 316 stainless steel stud 222 that exits cell 210. Water is directed through each cell, perpendicular to plates 216, in between the plates 216, in a direction indicated by arrow 224. The water flow rate through each cell typically is adjusted to be laminar and can be calibrated with a non-invasive flow meter and logged.
- An example of circuitry for operating reaction chamber 122 (Fig. 1) can be described as follows.
- An isolation transformer (k-8) steps down the primary 600 volts 3 -phase from a power supply to a multiple tap secondary of 10-20 volts alternating current (AC), 3-phase.
- the 3-phase AC secondary is fed into a thyristor, for example, a 500 amp three phase thyristor direct current (DC) converter for conversion to DC.
- the thyristor includes twelve silicon controlled rectifiers arranged as a four quadrant operation.
- the thyristor is employed to excite the cells with six silicon controlled rectifiers (SCR) and a four quadrant circuit arrangement.
- Reaction chamber 122 is gate-triggered into conduction by firing boards.
- Reaction output load is fed into diversionary board.
- PLC 144 enables a PID ramp sequence that applies DC to the cells in the reaction chamber. Cell amps and voltages are ramped up and down as a function of time to excite the cell electrode plates.
- Alternation of DC power can be reversed to the cells about, for example, every 30 minutes.
- Currents are first applied at, for example, about 5.0 amps DC per cell at voltages that are relevant to the conductivity of the incoming supply water.
- Time ramping begins and continues until about 10 amps per cell can be maintained.
- the complete production process can run about 3.5 to 4 hours under these conditions, producing about 3280 US gallons of water having about 28 to about 35 milligrams per liter of oxygen. Exemplary specifications for one example of the apparatus are provided in Example 6.
- ESW Enhanced-solubility water
- ESW can contain approximately three times the normal oxygen content (i.e., 28-35 mg/1). It is also believed that this enhanced concentration in oxygen can remain elevated in an open container for more than one day. After agitation (stirring), few or no bubbles are typically formed and there is little or no decrease in oxygen content compared to that observed when water is conventionally oxygenated, e.g., pressurized with oxygen.
- the increased oxygen solubility of ESW is believed to be related to a change in water structure resulting from the process, which includes electromagnetic treatment. This treatment increases the size of cavities in water, which can enhance the ability of water to assimilate more oxygen. Furthermore, the property of increased solubility seems to be retained after ESW is consumed and enters the bloodstream, as suggested by the improved performance in the Examples. The normal consumption and gastrointestinal absorption of ESW could result in improved oxygen solubility and diffusion in plasma. ESW in the bloodstream is believed to enhance the release of oxygen from red blood cells with the end result of increasing the efficiency of delivery of oxygen to tissues. The net effect of increased delivery is reflected in physiologic benefits in healthy people.
- the spontaneous transient cavities can be defined by a shell of water molecules which resembles a clathrate structure found in certain forms of ice (see illustration below).
- the average number OfH 2 O molecules forming the shell of these cavities capable to encapsulate inert and nonpolar gases is believed to be between 20 and 25 and the space enclosed by the shell is large enough to hold a single (monomeric) O 2 molecule, hi untreated water, the occurrence of large cavities, i.e. with a shell composed of greater than about 25 water molecules is believed to be rare since it is given by the exponential of the entropy cost to form the cavity in the bulk (work of cavity formation).
- the probability to observe a cavity composed of around 25 water molecules is roughly two orders of magnitude smaller than that to observe a cavity composed of 20 molecules.
- ESW which is believed to contain up to three times the amount of dissolved oxygen
- two or more oxygen molecules are believed to be contained in larger cavities whose shells are believed to be correspondingly larger.
- these larger shells are believed to be composed of more than about 35 H 2 O molecules.
- ESW is believed to be related to the existence of these multiple larger cavity shells consisting of more than about 35 H 2 O molecules.
- This study was a single blind, two-way crossover, tap water controlled, sub- maximal exercise study to determine the effect of ESW on heart rate during static sub-maximal bicycle exercise testing.
- Sixteen elite male and female cyclists utilizing their own bicycles were enrolled in the study.
- Baseline workload was standardized by determining each cyclist's lactate (anaerobic) threshold (LT) (Conconi Test) while performing a graded static exercise test at four resistance settings: (1) 80% of LT, (2) 80% +20 watts, (3) 80% +40 watts, (4) 80% +60 watts.
- LT anaerobic threshold
- the testing was performed on a computerized static testing stand (Compu Trainer Racer MateTM) utilizing a PC 1TM power pack. Heart rate was measured with a PolarX Training Heart RateTM monitor at the end of three minutes for each of the four resistance levels.
- the same baseline and repeat tests were performed again with the groups switching the type of water that was consumed.
- cardiac output and heart rate is well documented in the context of exercise performance.
- repeated exercise at a fixed resistance can be accomplished at a similar heart rate.
- training effects and variation in baseline parameters could be minimized by repeatedly testing each cyclist in a comparable sub-maximal range of four resistances.
- a comparison of each cyclist's heart rate during graded exercise before and after drinking ordinary tap water on one day revealed that there was no change in heart rate, confirming that there were no effects from the trial design which could produce a significant change in heart rate.
- This study was a single-blind, tap water controlled, sub-maximal exercise test to determine the effect of drinking ESW on the time taken to complete a simulated distance of five miles while pedaling at a predetermined heart rate during static sub-maximal bicycle exercise testing.
- each rider On the day before the test, each rider drank six 500 mL bottles of either tap water or ESW. The next day, over a 90 minute period beginning 120 minutes before the test, each rider drank three more 500 mL bottles. After a ten minute warm up, the riders performed a static test at a predetermined heart rate over a simulated distance of five miles. Monitors checked the heart rate to insure that the actual rate remained within two beats of the designated rate.
- absorption of ESW into the bloodstream is believed to improve the solubility of oxygen in plasma resulting in increased diffusion (extraction) of oxygen from red blood cells. Since oxygen availability to tissues depends upon the reciprocal relationship between cardiac output, reflected in heart rate, and oxygen extraction, the increased work output at a fixed heart rate is likely due to increased oxygen extraction.
- This study was a double-blind, tap water controlled, sub-maximal exercise study to determine the effect of drinking ESW on the time taken to complete a simulated distance often miles while pedaling at a predetermined heart rate during static sub-maximal bicycle exercise testing.
- each rider drank six 500 mL bottles of either tap water or ESW.
- each rider drank three more 500 mL bottles over a 90 minute period beginning 120 minutes before the test, if they weighed less than 140 pounds. If the rider weighed 140 pounds or more, they drank four 500 mL bottles over a 120 minute period beginning 150 minutes before the test.
- This study was a single-blind, tap water controlled, treadmill exercise test to determine the effects of drinking ESW on the onset, duration to maximum intensity and time to recovery of claudication (lower extremity pain) in patients with known lower extremity peripheral vascular disease.
- the treadmill test was performed at a fixed speed of 2.0 to 3.5 km/hr.
- the incline was started at 2% and was increased by 2% every 2 minutes until the termination of the test due to onset of pain.
- Measurements included time to start of lower extremity pain, end of maximum pain, and relief of pain; heart rate at rest, at the end of each 2 minute walking period, at the start of pain and at the relief of pain; and blood pressure at rest and at the relief of pain.
- the heart rate at the time of maximum pain was 80% of the expected age maximum for the patients confirming pain due to claudication rather than other causes. Consumption of ESW improved the longevity of work load (walking) by 10.4% and improved time to first pain by 13.6%. The delay in occurrence of maximum pain was statistically significant (p ⁇ 0.05). The recovery period after maximum pain was shortened by 31% after drinking ESW (pO.OOl). Heart rate was consistently lower in the group administered ESW compared to untreated water. ESW showed statistically significant physiological effects on the patients in this study. The onset of pain due to claudication in the lower extremities was delayed after the consumption of ESW. In addition, the recovery time after the onset of pain was shorter.
- Example 5 Double-Blind Claudication Pilot Study
- This study was a double-blind, tap water controlled, treadmill exercise test to determine the effects of drinking ESW on the onset, duration to maximum intensity, and time to recovery of lower extremity pain in patients with known lower extremity peripheral vascular disease (claudication).
- the treadmill test was performed at a fixed speed of 2.5 to 4.2 km/hr (Table 1).
- the incline started at 2% and was increased by 2% every 2 minutes until the termination of walking due to pain.
- Data obtained included time at end of maximum pain, and relief of pain, heart rate at rest , at the end of each 2 minutes of walking, at the end of maximum pain and at the relief of pain and blood pressure at rest and at the relief of pain.
- the testing results (duration of walking and recovery) are summarized in Table 2.
- Machine Specifications include:
- Controls include:
- Tank specifications include:
- the water can be re-circulated from the tank through the 40 cells in the reaction chamber and back to the tank by the main system pump which can be controlled by a frequency inverter.
- a proportional integral derivative closed loop control can be utilized.
- a second pump then re-circulates water from the bottom of the contact tank to a heat exchanger and then back to the top of the tank.
- a chiller unit refrigerates glycol which passes through the heat exchanger and chills the water to the constant range of 33 0 F to 35 0 F.
- a mixing chamber can be created in the tank. An amalgamation of semi- excited water and excited water can be mixed.
- a pressurized clean air blanket can be induced on the set level of water.
- a gap of 12 inches can be maintained on the dome.
- a constant regulated air pressure of 35 psi can be maintained on the vessel.
- An output instruction can be used to control pressure, liquid level, and the flow rate of the process loop. The instruction controls a closed loop using inputs from an analog input module and providing an output to an analog output module as a response to effectively hold a process variable at a desired set point.
- the electrical circuitry consists of an isolation transformer (k-8) windings that step down the primary 600 volts 3ph to a multiple tap secondary of 10-20 volts AC, 3ph.
- the 3ph AC secondary can be fed into a 500 amp Thyristor for conversion.
- a three phase Thyristor DC converter can be utilized for cell excitement with 6 SCR'S and a 4 quadrant circuit arrangement.
- the reactor can be gate triggered into conduction via firing boards.
- the reaction output load can be fed into a divisionary board.
- a PLC enables a PID ramp sequence that applies direct current to the cells. Cell amps and voltages can be time ramped up and down to excite the cell plates. Alternation of DC power to the cells can be reversed every 30 minutes. Currents can be first applied at 5.0 amp DC per cell and voltages that can be relevant to the conductivity of incoming supply water. Time ramping begins and continues until approximately 10 amps per cell can be maintained.
- Cells can be constructed with 3" rigid PVC tube approximately 47.5" long with a PVC plate spacer inset and tightly enclosed. A separate end cap holds the cell assembly in place. There can be 2 sections of 4 flat plates approximately 40" in length and 2" wide made of Titanium with a plating of 100 Micron Inches U of Platinum coating in order to achieve maximum conduction. The plates can be spaced at 0.250 inch between the positive and negative sets. They can be terminated with a stainless steel 316 stud that exits the cell.
- the water flow rate per cell can be laminar and calibrated with a non-evasive flow meter and logged.
- the complete production process runs 3.5 to 4 hours in a closed loop system with the reaction chamber (cells), contact tank and chilling unit. This produces approximately 3280 US gallons of water in the range of 24-30mg/l of O 2 .
- the process comprises electromagnetic treatment of excited water under constant mixing, pressure and electrical pulse ramping. This process could be used to create oxygen cavities in virtually any liquid solution.
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hydrology & Water Resources (AREA)
- Environmental & Geological Engineering (AREA)
- Water Supply & Treatment (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Electrochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Water Treatment By Electricity Or Magnetism (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)
- Oxygen, Ozone, And Oxides In General (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007530033A JP2008510617A (en) | 2004-08-23 | 2005-08-22 | Method and apparatus for preparing water with high oxygen solubility |
BRPI0514567-8A BRPI0514567A (en) | 2004-08-23 | 2005-08-22 | apparatus and method for increasing oxygen solubility in water and resulting product |
CA002577876A CA2577876A1 (en) | 2004-08-23 | 2005-08-22 | Method and apparatus for preparing water having increased oxygen solubility |
EP05790375A EP1781575A1 (en) | 2004-08-23 | 2005-08-22 | Method and apparatus for preparing water having increased oxygen solubility |
MX2007002067A MX2007002067A (en) | 2004-08-23 | 2005-08-22 | Method and apparatus for preparing water having increased oxygen solubility. |
AU2005277149A AU2005277149A1 (en) | 2004-08-23 | 2005-08-22 | Method and apparatus for preparing water having increased oxygen solubility |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60389304P | 2004-08-23 | 2004-08-23 | |
US60/603,893 | 2004-08-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2006023876A1 true WO2006023876A1 (en) | 2006-03-02 |
Family
ID=35455942
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/029845 WO2006023876A1 (en) | 2004-08-23 | 2005-08-22 | Method and apparatus for preparing water having increased oxygen solubility |
Country Status (9)
Country | Link |
---|---|
US (2) | US20060081542A1 (en) |
EP (1) | EP1781575A1 (en) |
JP (1) | JP2008510617A (en) |
CN (1) | CN101014543A (en) |
AU (1) | AU2005277149A1 (en) |
BR (1) | BRPI0514567A (en) |
CA (1) | CA2577876A1 (en) |
MX (1) | MX2007002067A (en) |
WO (1) | WO2006023876A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006135760A2 (en) * | 2005-06-09 | 2006-12-21 | Otec Research, Inc. | Apparatus and process for the electromagnetic sanitization of water |
US8709231B2 (en) | 2007-12-21 | 2014-04-29 | Compagnie Gervais Danone | Method for enriching water with oxygen by an electrolytic process, oxygen enriched water or beverage and uses thereof |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4831480B2 (en) * | 2006-06-21 | 2011-12-07 | 三浦工業株式会社 | Membrane filtration system |
US20090071190A1 (en) * | 2007-03-26 | 2009-03-19 | Richard Potthoff | Closed cycle mixed refrigerant systems |
US20090246234A1 (en) * | 2008-04-01 | 2009-10-01 | Benjamin Johnson | Therapeutic Treatment Using Niacin for Skin Disorders |
US8642655B2 (en) | 2011-03-09 | 2014-02-04 | Benjamin Johnson | Systems and methods for preventing cancer and treating skin lesions |
US9815714B2 (en) | 2012-12-11 | 2017-11-14 | Slate Group, Llc | Process for generating oxygenated water |
CN107368638A (en) * | 2017-07-10 | 2017-11-21 | 广东电网有限责任公司电力科学研究院 | A kind of traction electric machine transformer multiple physical field method for numerical simulation and device |
CN109997765B (en) * | 2019-04-10 | 2021-03-26 | 华南农业大学 | A device for running water formula fish exposes experiment |
BR102020016174A2 (en) * | 2020-08-07 | 2022-02-15 | Andrade Gutierrez Engenharia S.A. | Process and device for the magnetic activation of water and system for the production of concrete and mortar |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1508849A (en) * | 1974-07-03 | 1978-04-26 | Beeston Co Ltd | Electrolysis apparatus and method |
US4179347A (en) * | 1978-02-28 | 1979-12-18 | Omnipure, Inc. | System for electrocatalytic treatment of waste water streams |
DD215301A2 (en) * | 1983-03-08 | 1984-11-07 | Inst Hochseefischerei | METHOD AND CIRCUIT ARRANGEMENT FOR PREPARING WATER FROM FISH GROWING SYSTEMS |
US6217712B1 (en) * | 1996-12-04 | 2001-04-17 | Thomas J. Mohr | Catalytic simulation using radio frequency waves |
US6547947B1 (en) * | 1999-03-15 | 2003-04-15 | Permelec Electrode Ltd. | Method and apparatus for water treatment |
WO2005108304A1 (en) * | 2004-05-12 | 2005-11-17 | Mikhnevich Vladimir V | Method and apparatus for liquid treatment |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1989499A (en) * | 1931-03-18 | 1935-01-29 | Sabot Rene Charles | Device for promoting chemical reactions and particularly the combustion of mixtures of gases and other materials, such as vapors, liquids, and colloids |
US2518845A (en) * | 1945-05-05 | 1950-08-15 | E A Kent | Deaerator and corrosion control equipment |
US3836994A (en) * | 1969-05-01 | 1974-09-17 | Gen Electric | Thyristor overvoltage protective element |
US4005014A (en) * | 1974-05-17 | 1977-01-25 | Arnold Wikey | Water treatment system with prolonged aeration |
US4457221A (en) * | 1980-12-23 | 1984-07-03 | Geren David K | Sterilization apparatus |
US4682266A (en) * | 1985-04-22 | 1987-07-21 | National Distillers And Chemical Corporation | Ozonator power supply employing a current source inverter |
US5464513A (en) * | 1994-01-11 | 1995-11-07 | Scientific Utilization, Inc. | Method and apparatus for water decontamination using electrical discharge |
US5728287A (en) * | 1996-10-31 | 1998-03-17 | H2 O Technologies, Ltd. | Method and apparatus for generating oxygenated water |
US6171469B1 (en) * | 1996-10-31 | 2001-01-09 | H2O Technologies, Ltd. | Method and apparatus for increasing the oxygen content of water |
JP3019052B2 (en) * | 1997-12-09 | 2000-03-13 | 日新電機株式会社 | Liquid material sterilizer |
JP2000225175A (en) * | 1999-02-04 | 2000-08-15 | Nissin Electric Co Ltd | Sterilizer for liquid |
US6391184B1 (en) * | 1999-12-17 | 2002-05-21 | H2O Technologies, Ltd. | Decontamination method and system, such as an in-situ groundwater decontamination system, producing dissolved oxygen and reactive initiators |
ATE358654T1 (en) * | 2001-06-26 | 2007-04-15 | Aquafin N V | METHOD AND DEVICE FOR TREATING AQUEOUS SOLUTIONS CONTAINING COD |
US6801027B2 (en) * | 2002-09-26 | 2004-10-05 | Itt Manufacturing Enterprises, Inc. | Power conversion in variable load applications |
JP2004143519A (en) * | 2002-10-23 | 2004-05-20 | Denso Corp | Water treatment method and water treatment device |
US6746613B2 (en) * | 2002-11-04 | 2004-06-08 | Steris Inc. | Pulsed electric field system for treatment of a fluid medium |
US20040203166A1 (en) * | 2003-04-11 | 2004-10-14 | Sullivan John Timothy | Electrolysis apparatus and method utilizing at least one coiled electrode |
US6945125B2 (en) * | 2003-12-03 | 2005-09-20 | Daniel Industries, Inc. | High resolution pulse count interface |
-
2005
- 2005-08-22 EP EP05790375A patent/EP1781575A1/en not_active Withdrawn
- 2005-08-22 BR BRPI0514567-8A patent/BRPI0514567A/en not_active IP Right Cessation
- 2005-08-22 CN CNA2005800283796A patent/CN101014543A/en active Pending
- 2005-08-22 WO PCT/US2005/029845 patent/WO2006023876A1/en active Application Filing
- 2005-08-22 MX MX2007002067A patent/MX2007002067A/en unknown
- 2005-08-22 US US11/209,176 patent/US20060081542A1/en not_active Abandoned
- 2005-08-22 JP JP2007530033A patent/JP2008510617A/en active Pending
- 2005-08-22 AU AU2005277149A patent/AU2005277149A1/en not_active Abandoned
- 2005-08-22 CA CA002577876A patent/CA2577876A1/en not_active Abandoned
-
2011
- 2011-01-26 US US13/013,878 patent/US20110114491A1/en not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1508849A (en) * | 1974-07-03 | 1978-04-26 | Beeston Co Ltd | Electrolysis apparatus and method |
US4179347A (en) * | 1978-02-28 | 1979-12-18 | Omnipure, Inc. | System for electrocatalytic treatment of waste water streams |
DD215301A2 (en) * | 1983-03-08 | 1984-11-07 | Inst Hochseefischerei | METHOD AND CIRCUIT ARRANGEMENT FOR PREPARING WATER FROM FISH GROWING SYSTEMS |
US6217712B1 (en) * | 1996-12-04 | 2001-04-17 | Thomas J. Mohr | Catalytic simulation using radio frequency waves |
US6547947B1 (en) * | 1999-03-15 | 2003-04-15 | Permelec Electrode Ltd. | Method and apparatus for water treatment |
WO2005108304A1 (en) * | 2004-05-12 | 2005-11-17 | Mikhnevich Vladimir V | Method and apparatus for liquid treatment |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006135760A2 (en) * | 2005-06-09 | 2006-12-21 | Otec Research, Inc. | Apparatus and process for the electromagnetic sanitization of water |
WO2006135760A3 (en) * | 2005-06-09 | 2007-02-08 | Otec Res Inc | Apparatus and process for the electromagnetic sanitization of water |
US8709231B2 (en) | 2007-12-21 | 2014-04-29 | Compagnie Gervais Danone | Method for enriching water with oxygen by an electrolytic process, oxygen enriched water or beverage and uses thereof |
Also Published As
Publication number | Publication date |
---|---|
CN101014543A (en) | 2007-08-08 |
US20110114491A1 (en) | 2011-05-19 |
EP1781575A1 (en) | 2007-05-09 |
US20060081542A1 (en) | 2006-04-20 |
MX2007002067A (en) | 2007-10-16 |
CA2577876A1 (en) | 2006-03-02 |
BRPI0514567A (en) | 2008-06-17 |
JP2008510617A (en) | 2008-04-10 |
AU2005277149A1 (en) | 2006-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20110114491A1 (en) | Enhanced-solubility water | |
JP5865560B1 (en) | Gas dissolving apparatus and gas dissolving method | |
RU2492146C2 (en) | Method of enriching water with oxygen by electrolytic process, oxygen-enriched water or beverage and use thereof | |
JP3770776B2 (en) | Method for producing a supersaturated oxygenated liquid | |
EP1444903B1 (en) | Method for producing ultrafine dispersion water of noble metal ultrafine particles | |
KR20150101696A (en) | Generation device of hydrogen water | |
WO2008072615A1 (en) | Functional water and process for producing the same | |
AU2002237540B2 (en) | Method and device for manufacturing advanced water containing ultra-fine gold particles | |
TWI327989B (en) | Making method and apparatus for dissolving fluid of carbon dioxide gas and carbonated water | |
CN105696012A (en) | Multifunctional hydrogen machine | |
JP2003019426A (en) | Method and system for producing gas dissolving liquid medium | |
JP2003088736A (en) | Apparatus and method for increasing concentration of dissolved gas | |
JP2016087523A (en) | Manufacturing method of gas dispersion liquid | |
JP2017131822A (en) | Hydrogen water generator and hydrogen water generation method | |
JP2017196572A (en) | Hydrogen content reduction inhibitor of hydrogen-containing liquid, hydrogen content reduction inhibition method of hydrogen-containing liquid and manufacturing method of hydrogen-containing liquid | |
EP0847959B1 (en) | Method for preparing and filling of oxygen-enriched or oxygen containing gas enriched liquids and beverage prepared by such a method | |
DE19817890A1 (en) | Enriching drinking water with dissolved carbon dioxide and oxygen | |
KR100638811B1 (en) | Apparatus for making superoxygenated water | |
KR101788228B1 (en) | Poorly water-soluble gas disolved gas water manufacturing system and method | |
KR20100110911A (en) | Micro-nano oxygen bubble fish fainting and anesthesia apparatus and method | |
CN210457816U (en) | Device for preparing water containing steady active oxygen | |
US20240262673A1 (en) | Water dispensing device | |
KR20160047085A (en) | Apparatus System and Method for Generating Highly Functional Nanobubble Gas Water by means of Vapour Dilution based on Asepsis | |
CN204999659U (en) | Novel burden hydrogen running water appearance | |
CN100336747C (en) | Small molecule water and its prepn process and preparing activator |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2005790375 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 553198 Country of ref document: NZ Ref document number: 2005277149 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/a/2007/002067 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2577876 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007530033 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200580028379.6 Country of ref document: CN |
|
ENP | Entry into the national phase |
Ref document number: 2005277149 Country of ref document: AU Date of ref document: 20050822 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2005277149 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2005790375 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: PI0514567 Country of ref document: BR |